Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 76Leukemia, Myeloid, Acute 70Prostatic Neoplasms 67Neoplasm Metastasis 56Carcinoma, Non-Small-Cell Lung 56Breast Neoplasms 45Multiple Myeloma 44Colorectal Neoplasms 40Pancreatic Neoplasms 36Myelodysplastic Syndromes 35Carcinoma, Renal Cell 33Ovarian Neoplasms 31Leukemia, Lymphocytic, Chronic, B-Cell 30Melanoma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Glioblastoma 27Triple Negative Breast Neoplasms 26Lymphoma, Large B-Cell, Diffuse 26Urinary Bladder Neoplasms 24Lymphoma 23Burkitt Lymphoma 22Squamous Cell Carcinoma of Head and Neck 21Glioma 20Fallopian Tube Neoplasms 20Carcinoma, Hepatocellular 18Mouth Neoplasms 17Leukemia, Biphenotypic, Acute 17Brain Neoplasms 17Sarcoma 16Oropharyngeal Neoplasms 16

Interventions

Cisplatin 13Paclitaxel 10Ifosfamide 10Etoposide 10Filgrastim 8Bleomycin 8Carboplatin 7pegfilgrastim 3Peripheral Blood Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3liposomal amphotericin B 2etoposide phosphate 2Therapeutics 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Drug Therapy 2Cyclophosphamide 2sargramostim 1sabarubicin 1ixabepilone 1aldesleukin 1Vincristine 1Vinblastine 1Thiotepa 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Specimen Handling 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endodermal Sinus Tumor × Specimen Handling × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡